![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, July 25, 2016 1:55:23 PM
Medtronic anticipates approval in the spring next year. If approved, it will be the world's first "artificial pancreas." The system comprises Medtronic's MiniMed 670G insulin pump, fourth-generation glucose monitors and a control algorithm. The sensors are worn for 7 days before they need recharging, while the insulin pump needs to be refilled every three days, Bloomberg reported.
The submission is based on pivotal data, which Medtronic presented to the American Diabetes Association conference earlier this month. The data showed that the system helped to lower A1c levels and maintain more consistent blood glucose sensor values in 124 patients with Type 1 diabetes. No adverse events were reported in the study, which spanned 12,389 patient days. At the end of the study, most of the patients chose to join the continued-access program for the device.
A separate study involving 12 adults and 16 adolescents showed that overnight use of the closed-loop system reduced the time adults needed to get to their target glucose range and decreased nocturnal hypoglycemia for the adolescents.
Medtronic is leading the race to get an artificial pancreas to market, but the device giant isn't stopping there. It is working on a fully closed-loop system using its new Harmony 1 sensor, which is expected to last 10 days. The company also expects it to be more accurate and require just one calibrating finger-stick a day, rather than the twice-daily requirement of most continuous glucose monitors.
The artificial pancreas could ramp up Medtronic's diabetes business, which booked $496 million in revenues in the most recent quarter, which ended May 31. The Diabetes Group accounted for 7% of the company's business and grew 10% last year, with insulin pump sales growing 30% outside the U.S. The company will accelerate in diabetes, with plans to roll out "more new products in the next 5 years than we have in the last 15 years," said Diabetes Group President Hooman Hakami at an investor day earlier this year.
Recent MDT News
- Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference • PR Newswire (Canada) • 08/27/2024 11:02:00 PM
- Medtronic chairman and CEO Geoff Martha to speak at the Wells Fargo Healthcare Conference • PR Newswire (US) • 08/27/2024 11:02:00 PM
- Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). • Edgar (US Regulatory) • 08/27/2024 08:19:06 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/27/2024 08:18:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 08:11:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/20/2024 10:46:44 AM
- Medtronic reports first quarter fiscal 2025 financial results • PR Newswire (Canada) • 08/20/2024 10:45:00 AM
- Medtronic reports first quarter fiscal 2025 financial results • PR Newswire (US) • 08/20/2024 10:45:00 AM
- U.S. Index Futures Hold Steady, Oil Prices Drop • IH Market News • 08/20/2024 09:58:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/19/2024 08:20:24 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/16/2024 11:01:42 AM
- Medtronic announces cash dividend for second quarter of fiscal year 2025 • PR Newswire (Canada) • 08/16/2024 11:00:00 AM
- Medtronic announces cash dividend for second quarter of fiscal year 2025 • PR Newswire (US) • 08/16/2024 11:00:00 AM
- Google Forced to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys Kellanova • IH Market News • 08/15/2024 10:05:46 AM
- Google Mandated to Modify Play Store, Apple Innovates, Victoria’s Secret Hires CEO, Mars Buys Kellanova • IH Market News • 08/15/2024 10:05:46 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 10:03:52 PM
- Medtronic to announce financial results for its first quarter of fiscal year 2025 • PR Newswire (US) • 08/12/2024 07:01:00 PM
- Medtronic to announce financial results for its first quarter of fiscal year 2025 • PR Newswire (Canada) • 08/12/2024 07:01:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/09/2024 08:36:06 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/09/2024 08:31:39 PM
- Medtronic announces FDA approval of Simplera™ CGM and global partnership with Abbott • PR Newswire (US) • 08/07/2024 12:00:00 PM
- Medtronic announces FDA approval of Simplera™ CGM and global partnership with Abbott • PR Newswire (Canada) • 08/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:15:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:14:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/06/2024 10:12:46 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM